| Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response PT Liu, S Stenger, H Li, L Wenzel, BH Tan, SR Krutzik, MT Ochoa, ... Science 311 (5768), 1770-1773, 2006 | 4892 | 2006 |
| Induction of direct antimicrobial activity through mammalian toll-like receptors S Thoma-Uszynski, S Stenger, O Takeuchi, MT Ochoa, M Engele, ... Science 291 (5508), 1544-1547, 2001 | 978 | 2001 |
| Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses J Kim, MT Ochoa, SR Krutzik, O Takeuchi, S Uematsu, AJ Legaspi, ... The Journal of Immunology 169 (3), 1535-1541, 2002 | 895 | 2002 |
| TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells SR Krutzik, B Tan, H Li, MT Ochoa, PT Liu, SE Sharfstein, TG Graeber, ... Nature medicine 11 (6), 653-660, 2005 | 583 | 2005 |
| Activation and regulation of Toll-like receptors 2 and 1 in human leprosy SR Krutzik, MT Ochoa, PA Sieling, S Uematsu, YW Ng, A Legaspi, PT Liu, ... Nature medicine 9 (5), 525-532, 2003 | 472 | 2003 |
| Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells RE Hunger, PA Sieling, MT Ochoa, M Sugaya, AE Burdick, TH Rea, ... The Journal of clinical investigation 113 (5), 701-708, 2004 | 390 | 2004 |
| Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogens BH Tan, C Meinken, M Bastian, H Bruns, A Legaspi, MT Ochoa, ... The Journal of Immunology 177 (3), 1864-1871, 2006 | 344 | 2006 |
| Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10 S Thoma-Uszynski, SM Kiertscher, MT Ochoa, DA Bouis, MV Norgard, ... The Journal of Immunology 165 (7), 3804-3810, 2000 | 313 | 2000 |
| Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma A Ribas, B Comin-Anduix, B Chmielowski, J Jalil, P de la Rocha, ... Clinical Cancer Research 15 (19), 6267-6276, 2009 | 249 | 2009 |
| Expression of Toll-like receptor 2 on human Schwann cells: a mechanism of nerve damage in leprosy RB Oliveira, MT Ochoa, PA Sieling, TH Rea, A Rambukkana, EN Sarno, ... Infection and immunity 71 (3), 1427-1433, 2003 | 228 | 2003 |
| Divergence of macrophage phagocytic and antimicrobial programs in leprosy D Montoya, D Cruz, RMB Teles, DJ Lee, MT Ochoa, SR Krutzik, R Chun, ... Cell host & microbe 6 (4), 343-353, 2009 | 225 | 2009 |
| T-cell release of granulysin contributes to host defense in leprosy MT Ochoa, S Stenger, PA Sieling, S Thoma-Uszynski, S Sabet, S Cho, ... Nature medicine 7 (2), 174-179, 2001 | 225 | 2001 |
| Use of genetic profiling in leprosy to discriminate clinical forms of the disease JR Bleharski, H Li, C Meinken, TG Graeber, MT Ochoa, M Yamamura, ... Science 301 (5639), 1527-1530, 2003 | 224 | 2003 |
| Evolution of the Late Miocene Mediterranean–Atlantic gateways and their impact on regional and global environmental change R Flecker, W Krijgsman, W Capella, C de Castro Martíns, E Dmitrieva, ... Earth-Science Reviews 150, 365-392, 2015 | 209 | 2015 |
| Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy D Cruz, AD Watson, CS Miller, D Montoya, MT Ochoa, PA Sieling, ... The Journal of clinical investigation 118 (8), 2917-2928, 2008 | 189 | 2008 |
| IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection VE García, K Uyemura, PA Sieling, MT Ochoa, CT Morita, H Okamura, ... The Journal of Immunology 162 (10), 6114-6121, 1999 | 183 | 1999 |
| “Dermal dendritic cells” comprise two distinct populations: CD1+ dendritic cells and CD209+ macrophages MT Ochoa, A Loncaric, SR Krutzik, TC Becker, RL Modlin Journal of investigative dermatology 128 (9), 2225-2231, 2008 | 169 | 2008 |
| TLR activation of Langerhans cell-like dendritic cells triggers an antiviral immune response CN Renn, DJ Sanchez, MT Ochoa, AJ Legaspi, CK Oh, PT Liu, SR Krutzik, ... The Journal of immunology 177 (1), 298-305, 2006 | 168 | 2006 |
| Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species. R Palacios, LE Osorio, LF Grajalew, MT Ochoa The American journal of tropical medicine and hygiene 64 (3), 187-193, 2001 | 166 | 2001 |
| NOD2 triggers an interleukin-32–dependent human dendritic cell program in leprosy M Schenk, SR Krutzik, PA Sieling, DJ Lee, RMB Teles, MT Ochoa, ... Nature medicine 18 (4), 555-563, 2012 | 149 | 2012 |
